Search Results
399 results
Your search is now limited to «Pfizer» expert search. 03/22/2019 21:55
Pfizer Steps Further In The Door For Gene Therapies.
More from
Seeking Alpha 03/22/2019 20:55
Pfizer's Gene Therapy Push Pfizer has taken a 15% stake in a privately held biotech by the name of Vivet Therapeutics.
More from Seeking Alpha: 03/21/2019 10:53
Conditions : Psoriasis Vulgaris; Psoriasis Arthropathica; Pustular Psoriasis; Erythrodermic Psoriasis Intervention : Drug: Infliximab [infliximab biosimilar 3] Sponsor : Pfizer Not yet recruiting.
More from
PharmaTimes 03/21/2019 09:05
Mikael Dolsten, Pfizer chief scientific officer and president, Worldwide Research, Development, and Medical, said: “Pfizer strives to provide meaningful enhancements to the lives of patients with rare diseases.
More from PharmaTimes:
World Pharma News 03/21/2019 07:00
Pfizer secures exclusive option to acquire gene therapy company Vivet Therapeutics.
More from World Pharma News:
US pharmaceutical company Pfizer has secured an exclusive option to acquire gene therapy firm Vivet Therapeutics in a deal that could be valued at around €560m ($635.8m.
More from Pharmaceutical Business Review:
24/7 Wall Street 03/20/2019 16:25
On top of the investment in the French company, Pfizer also now has an exclusive option that would allow it to take full ownership of the company.
More from 24/7 Wall Street: 03/20/2019 11:30
Though Bavencio is a relatively new drug in Pfizer’s oncology portfolio and is currently approved for two relatively smaller indications, it might emerge as a key long-term growth driver for Pfizer on future label expansion approvals.
More from 03/20/2019 11:07
In a joint statement on Wednesday, Vivet and Pfizer said Pfizer can exercise its option to acquire all of Vivet following its delivery of certain data from an early-stage clinical trial for its VTX-801, an experimental treatment for Wilson disease.
More from
ENDPOINTS 03/20/2019 09:51
EMA sounds it’s own safety alarm for Pfizer blockbuster, but they’re also not forcing a limit on dosing — yet – Endpoints News.
More from ENDPOINTS:
Benzinga 03/20/2019 07:46
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks. (Biotech stocks hitting 52-week highs on March 19). Abbott Laboratories (NYSE: ABT ). AstraZeneca plc (NYSE: AZN ). Axsome Therapeutics Inc (NASDAQ: AXSM ). CYCLERION THERA/SH (NASDAQ: CYCNV ). Glaukos Corp (NYSE: GKOS ). Millendo Therapeutics Inc (NASDAQ: MLND )(initiates Phase 2b/3 study for its investigational candidate livoletide for treating Prader-Willi syndrome). Orthopediatrics Corp (NASDAQ: KIDS ). Zoetis Inc (NYSE: ZTS ). Down In The Dumps. (Biotech stocks hitting 52-week lows on March 19). Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ). resTORbio, Inc. (NASDAQ: TORC ) (announced a common stock offering). See Also: Attention Biotech Investors: Mark

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications